Tgf Beta1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TGF-beta1 is synthesized as a precursor that forms a latent complex with latency-associated peptide (LAP). The active dimer (12.8 kDa per monomer) is released by proteolytic cleavage or conformational change. Each monomer contains nine conserved cystines forming disulfide bonds.
Normal Function
...
TGF-beta1 Protein
Introduction
Tgf Beta1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TGF-beta1 is synthesized as a precursor that forms a latent complex with latency-associated peptide (LAP). The active dimer (12.8 kDa per monomer) is released by proteolytic cleavage or conformational change. Each monomer contains nine conserved cystines forming disulfide bonds.
Normal Function
TGF-beta1 has diverse biological activities:
Neuroprotection and neurotrophic effects
Regulation of synaptic plasticity
Anti-inflammatory effects on [microglia](/cell-types/microglia-neuroinflammation)
Promotion of astrocyte reactivity
Regulation of [blood-brain barrier](/entities/blood-brain-barrier) integrity
Role in Disease
[Alzheimer's Disease](/diseases/alzheimers-disease): Elevated TGF-beta1 in AD brains. Promotes amyloid accumulation but also has neuroprotective effects. The balance is critical.
[Parkinson's Disease](/diseases/parkinsons-disease): TGF-beta1 protects dopaminergic [neurons](/entities/neurons); reduced signaling may contribute to degeneration.
Transforming Growth Factor Beta 1 (TGF-beta1) is a protein involved in neuroinflammation, immune regulation, and neurodegenerative diseases. It plays critical roles in cell signaling, immune response, and disease pathogenesis.
The study of Tgf Beta1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[Heneka MT, Carson MJ, El Khoury J, et al, Neuroinflammation in Alzheimer's disease (2015)](https://doi.org/10.1016/S1474-4422(15))
[Ransohoff RM, How neuroinflammation contributes to neurodegeneration (2016)](https://doi.org/10.1126/science.aag2590))
[Song WM, Colonna M, The identity and function of microglia in neurodegeneration (2018)](https://doi.org/10.1038/s41590-018-0212-1))
[Wolf Y, Yona S, Kim KW, Jung S, Microglia, seen from the TNF side (2017)](https://doi.org/10.1038/nri.2016.144))
[Prinz M, Priller J, The role of peripheral immune cells in the CNS in steady state and disease (2017)](https://doi.org/10.1038/nn.4475))
[Deczkowska A, Amit I, Schwartz M, Microglial immune checkpoint mechanisms (2018)](https://doi.org/10.1038/s41593-018-0144-y))
[Keren-Shaul H, Spinrad A, Weiner A, et al, A unique microglia type associated with restricting development of Alzheimer's disease (2017)](https://doi.org/10.1016/j.cell.2017.05.018))